65 related articles for article (PubMed ID: 3922020)
1. Studies on the stability of 3H-dopamine, 3H-apomorphine and 3H-ADTN: effects of sodium ascorbate and EDTA.
Cabbat FS; Manzino L; Heikkila RE
Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):333-43. PubMed ID: 3922020
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes.
Arana GW; Baldessarini RJ; Kula NS
Neuropharmacology; 1982 Jun; 21(6):601-4. PubMed ID: 6810198
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific binding of 3H-dopamine in neostriatal membrane preparations: inhibitory effects of sodium ascorbate.
Heikkila RE; Cabbat FS; Manzino L
Life Sci; 1983 May; 32(19):2183-91. PubMed ID: 6843291
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibitory effects of ascorbic acid on the binding of dopamine agonists and antagonists to neostriatal membrane preparations: correlations with behavioral effects.
Heikkila RE; Cabbat FS; Manzino L
Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):409-21. PubMed ID: 7323442
[TBL] [Abstract][Full Text] [Related]
5. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
Seeman P; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
[TBL] [Abstract][Full Text] [Related]
6. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
Bradbury AJ; Costall B; Naylor RJ
J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
[TBL] [Abstract][Full Text] [Related]
7. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
Buczko W; De Blasi A
Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
[TBL] [Abstract][Full Text] [Related]
8. Effects of radioligand oxidation and ascorbate-induced lipid peroxidation on serotonin-1 receptor assay: use of ascorbate and ethylenediamine tetraacetic acid buffers to prevent (3H)-5-HT binding artifacts.
May PC; Morgan DG; Salo D; Goss JR; Finch CE
J Neurosci Res; 1988; 20(2):257-62. PubMed ID: 3139891
[TBL] [Abstract][Full Text] [Related]
9. Ascorbate induced lipid peroxidation results in loss of receptor binding in tris, but not in phosphate, buffer. Implications for the involvement of metal ions.
Abe K; Kogure K; Arai H; Nakano M
Biochem Int; 1985 Sep; 11(3):341-8. PubMed ID: 3933512
[TBL] [Abstract][Full Text] [Related]
10. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
List SJ; Seeman P
J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
[TBL] [Abstract][Full Text] [Related]
11. Studies on the stability of 3H-dopamine in neostriatal membrane preparations: effects of Ascorbic acid.
Heikkila RE; Cabbat FS
Life Sci; 1983 Feb; 32(8):847-53. PubMed ID: 6827915
[TBL] [Abstract][Full Text] [Related]
12. Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions.
Hirschhorn ID; Makman MH
Eur J Pharmacol; 1982 Sep; 83(1-2):61-7. PubMed ID: 7128701
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
[TBL] [Abstract][Full Text] [Related]
14. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
Osborne NN
Cell Mol Neurobiol; 1981 Jun; 1(2):167-74. PubMed ID: 7346167
[TBL] [Abstract][Full Text] [Related]
15. Binding of [3H]ADTN to rat striatal membranes.
Templeton WW; Woodruff GN
Biochem Pharmacol; 1982 Apr; 31(8):1629-32. PubMed ID: 6124259
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
Mulder TB; Grol CJ; Dijkstra D; Horn AS
Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139
[TBL] [Abstract][Full Text] [Related]
17. Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptors.
Chan B; Seeman P; Davis A; Madras BK
Eur J Pharmacol; 1982 Jun; 81(1):111-6. PubMed ID: 6126367
[TBL] [Abstract][Full Text] [Related]
18. Ascorbic acid and the binding of DA agonists to neostriatal membrane preparations.
Heikkila RE; Manzino L; Cabbat FS; Hanly JG
Neuropharmacology; 1983 Jan; 22(1):135-7. PubMed ID: 6843783
[TBL] [Abstract][Full Text] [Related]
19. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain.
Westerink BH; Dijkstra D; Feenstra MG; Horn AS; Rollema H
Eur J Pharmacol; 1980 Jun; 64(2-3):115-21. PubMed ID: 7398758
[TBL] [Abstract][Full Text] [Related]
20. Ascorbate-induced lipid peroxidation and inhibition of [3H]spiroperidol binding in neostriatal membrane preparations.
Heikkila RE; Cabbat FS
J Neurochem; 1983 Nov; 41(5):1384-92. PubMed ID: 6619873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
